RE:RE:RE:RE:RE:RE:RE:RE:What BTI Shares Are Worth TodayCraig, my son, my son, an NDA is a civil matter, not regulatory, unless selective disclosure is involved. Then all hell breaks loose. Remember, Bioasis has never cancelled my contract. If they had a problem, they could have done that. Instead, I cancelled it.
I love Bioasis leaks. There were many but there really was never anything worth leaking. The stock has been dropping from a high of $2.17 in 2012 to 3.5¢ today, and no leaks caused that. Nothing caused it, as in nothing has been accomplished that created value, so nothing caused it.
FinallyTheRock said "NOTHING" dozens of times. He was right, of course, although Bioasis was claiming that lots of things were going on. I think it likely that partners were doing some important things, but Bioasis may have essentially shut down months ago.
I say let's go for it. Full regulatory investigations. Bioasis's full 14 year history could stand a closer examination, including people who got never-disclosed options for promotion purposes, and CEO leaks and who kept the best documentation of every conversation and who signed false filings and interesting brokers and a whole bunch of stuff.
And The Big Question? Was there ever any intention of making something big out of the capabilities of p97. No peptide for 6 years. A decision to avoid the risk of in-house clinical development programs. Deals by Christmas. Leaks. Shareholders begging for leaks, expecting leaks because they were so used to them. Was Bioasis ever seriously put into play, or was it a pump that had brief recovery attempts, first with the peptide, and then Mark Day, only to fall into the hands that brought us to today's situation?
My internal debate is whether to write it all out and send it off. But the document would be the size of a book, which I have mentioned to great ridicule in the past. But a book could be written, nonfiction, or fiction, they'd be about the same.
TSXV and BCSC could then read the lines, and also between them.
jd